49
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: not found
      • Article: not found

      Home Use of an Artificial Beta Cell in Type 1 Diabetes

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          The feasibility, safety, and efficacy of prolonged use of an artificial beta cell (closed-loop insulin-delivery system) in the home setting have not been established.

          Related collections

          Most cited references22

          • Record: found
          • Abstract: found
          • Article: not found

          Outpatient glycemic control with a bionic pancreas in type 1 diabetes.

          The safety and effectiveness of automated glycemic management have not been tested in multiday studies under unrestricted outpatient conditions.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Glycaemic control of Type 1 diabetes in clinical practice early in the 21st century: an international comparison.

            Improving glycaemic control in people with Type 1 diabetes is known to reduce complications. Our aim was to compare glycaemic control among people with Type 1 diabetes using data gathered in regional or national registries.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: found
              Is Open Access

              Most Youth With Type 1 Diabetes in the T1D Exchange Clinic Registry Do Not Meet American Diabetes Association or International Society for Pediatric and Adolescent Diabetes Clinical Guidelines

              OBJECTIVE To assess the proportion of youth with type 1 diabetes under the care of pediatric endocrinologists in the United States meeting targets for HbA1c, blood pressure (BP), BMI, and lipids. RESEARCH DESIGN AND METHODS Data were evaluated for 13,316 participants in the T1D Exchange clinic registry younger than 20 years old with type 1 diabetes for ≥1 year. RESULTS American Diabetes Association HbA1c targets of <8.5% for those younger than 6 years, <8.0% for those 6 to younger than 13 years old, and <7.5% for those 13 to younger than 20 years old were met by 64, 43, and 21% of participants, respectively. The majority met targets for BP and lipids, and two-thirds met the BMI goal of <85th percentile. CONCLUSIONS Most children with type 1 diabetes have HbA1c values above target levels. Achieving American Diabetes Association goals remains a significant challenge for the majority of youth in the T1D Exchange registry.
                Bookmark

                Author and article information

                Journal
                New England Journal of Medicine
                N Engl J Med
                Massachusetts Medical Society
                0028-4793
                1533-4406
                November 26 2015
                November 26 2015
                : 373
                : 22
                : 2129-2140
                Article
                10.1056/NEJMoa1509351
                26379095
                1b5d1623-4c4f-412a-a391-b67e450f8438
                © 2015
                History

                Comments

                Comment on this article